Literature DB >> 32274764

TRIM E3 Ubiquitin Ligases in Rare Genetic Disorders.

Germana Meroni1.   

Abstract

The TRIM family comprises proteins characterized by the presence of the tripartite motif composed of a RING domain, one or two B-box domains and a coiled-coil region. The TRIM shared domain structure underscores a common biochemical function as E3 ligase within the ubiquitination cascade. The TRIM proteins represent one of the largest E3 ligase families counting in human more than 70 members. These proteins are implicated in a plethora of cellular processes such as apoptosis, cell cycle regulation, muscular physiology, and innate immune response. Consistently, their alteration results in several pathological conditions emphasizing their medical relevance. Here, the genetic and pathogenetic mechanisms of rare disorders directly caused by mutations in TRIM genes will be reviewed. These diseases fall into different pathological areas, from malformation birth defects due to developmental abnormalities, to neurological disorders and progressive teenage neuromuscular disorders. In many instances, TRIM E3 ligases act on several substrates thus exerting pleiotropic activities: the need of unraveling disease-specific TRIM pathways for a precise targeting therapy avoiding dramatic side effects will be discussed.

Entities:  

Keywords:  E3 ubiquitin ligases; RING domain; Rare genetic diseases; Tripartite motif, TRIM; Ubiquitination

Mesh:

Substances:

Year:  2020        PMID: 32274764     DOI: 10.1007/978-3-030-38266-7_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

Review 1.  TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases.

Authors:  Lorena Kumarasinghe; Lu Xiong; Maria Adelaida Garcia-Gimeno; Elisa Lazzari; Pascual Sanz; Germana Meroni
Journal:  Cells       Date:  2021-04-06       Impact factor: 6.600

2.  Elucidation of TRIM25 ubiquitination targets involved in diverse cellular and antiviral processes.

Authors:  Emily Yang; Serina Huang; Yasaman Jami-Alahmadi; Gerald M McInerney; James A Wohlschlegel; Melody M H Li
Journal:  PLoS Pathog       Date:  2022-09-06       Impact factor: 7.464

Review 3.  Tumor suppressor p53 cross-talks with TRIM family proteins.

Authors:  Juan Liu; Cen Zhang; Xue Wang; Wenwei Hu; Zhaohui Feng
Journal:  Genes Dis       Date:  2020-07-16

Review 4.  Microtubular TRIM36 E3 Ubiquitin Ligase in Embryonic Development and Spermatogenesis.

Authors:  Martina Mascaro; Inês Lages; Germana Meroni
Journal:  Cells       Date:  2022-01-12       Impact factor: 6.600

5.  Targeting TRIM54/Axin1/β-Catenin Axis Prohibits Proliferation and Metastasis in Hepatocellular Carcinoma.

Authors:  Jinrong Zhu; Yongqi Wu; Shaoxi Lao; Jianfei Shen; Yijian Yu; Chunqiang Fang; Na Zhang; Yan Li; Rongxin Zhang
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.